DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcoma

International Journal of Cancer

Volumn 84, Issue 2, 1999, Pages 114-121

  Tarkkanen, Maija ^a,b   Elomaa, Inkeri ^a   Blomqvist, Carl ^a   Kivioja, Aarne H ^a   Kellokumpu Lehtinen, Pirkko ^c   Böhling, Tom ^d   Valle, Julio ^d   Knuutila, Sakari ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BONE NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OSTEOSARCOMA; PROGNOSIS;

EID: 0033006029     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q     Document Type: Article

References (45)

1. ARMENGOL, G. and 15 OTHERS, Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridisation. Brit. J. Cancer, 75, 1403-1409 (1997).
2. BALDINI, N., SCOTLANDI, K., BARBANTI-BRODANO, G., MANARA, M.C., MAURICI, D., BACCI, G., BERTONI, F., PICCI, P., SOTTILI, S., CAMPANACCI, M. and SERRA, M., Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med., 333, 1380-1385 (1995).
3. BIELING, P. and 13 OTHERS, Tumor size and prognosis in aggressively treated osteosarcoma. J. clin. Oncol., 14, 848-858 (1996).
4. FEUGEAS, O. and 12 OTHERS, Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J. clin. Oncol., 14, 467-472 (1996).
5. FLETCHER, J.A., GEBHARDT, M.C. and KOZAKEWICH, H.P., Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and doubleminute chromosomes. Cancer Genet. Cytogenet., 77, 81-88 (1994).
6. FORUS, A., BERNER, J.-M., MEZA-ZEPEDA, L.A., SÆTER, G., MISCHKE, D., FODSTAD, Ø. and MYKLEBOST, O., Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Brit. J. Cancer, 78, 495-503 (1998).
7. FORUS, A., FLØRENES, V.A., MAELANDSMO, G.M., FODSTAD, Ø. and MYKLEBOST, O., The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genet. Cytogenet., 78, 165-171 (1994).
8. FORUS, A., WEGHUIS, D.O., SMEETS, D., FODSTAD, Ø., MYKLEBOST, O. and VAN KESSEL, A.G., Comparative genomic hybridization analysis of human sarcomas. II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer, 14, 15-21 (1995).
9. GEORGE, E., NIEHANS, G.A., SWANSON, P.E., STRICKLER, J.G. and SINGLETON, T.P., Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation. Arch. Pathol. Lab. Med., 116, 1033-1035 (1992).
10. HORSTMANN, M., POSL, M., SCHOLZ, R., ANDEREGG, B., SIMON, P., BAUMGAERTL, K., DELLINC, G. and KABISCH, H., Frequent reduction or loss of DCC gene expression in human osteosarcoma. Brit. J. Cancer, 75, 1309-1317 (1997).
11. HULSEBOS, T.J.M., BIJLEVELD, E.H., OSKAM, N.T., WESTERVELD, A., LEENSTRA, S., HOGENDOORN, P.C.W. and BRAS, J., Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas. Genes Chromosomes Cancer, 18, 279-285 (1997).
12. ISOLA, J.J., KALLIONIEMI, O.-P., CHU, L.W., FUQUA, S.A.W., HILSENBECK, S.G., OSBORNE, C.K. and WALDMAN, F.M., Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Amer. J. Pathol., 147, 905-911 (1995).
13. KALLIONIEMI, A., KALLIONIEMI, O.-P., SUDAR, D., RUTOVITZ, D., GRAY, J.W., WALDMAN, F. and PINKEL, D., Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258, 818-821 (1992).
14. KNUUTILA, S. and 14 OTHERS, DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Amer. J. Pathol., 152, 1107-1123 (1998).
15. KRUZELOCK, R.P., MURPHY, E.G., STRONG, L.C., NAYLOR, S.L. and HANSEN, M.F., Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res., 57, 106-109 (1997).
16. LADANYI, M., CHA, C., LEWIS, R., JHANWAR, S.C., HUVOS, A.G. and HEALEY, J.H., MDM2 gene amplification in metastatic osteosarcoma. Cancer Res., 53, 16-18 (1993a).
17. LADANYI, M., PARK, C.K., LEWIS, R., JHANWAR, S.C., HEALEY, J.H. and HUVOS, A.G., Sporadic amplification of the MYC gene in human osteosarcomas. Diagn. mol. Pathol., 2, 163-167 (1993b).
18. LARRAMENDY, M.L., TARKKANEN, M., BLOMQVIST, C., VIROLAINEN, M., WIKLUND, T., ASKO-SELJAVAARA, S., ELOMAA, I. and KNUUTILA, S., Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Amer. J. Pathol., 151, 1153-1161 (1997a).
19. LARRAMENDY, M.L., TARKKANEN, M., VALLE, J., KIVIOJA, A.H., ERVASTI, H., KARAHARJU, E., SALMIVALLI, T., ELOMAA, I. and KNUUTILA, S., Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Amer. J. Pathol., 150, 685-691 (1997b).
20. LARRAMENDY, M.L., VIROLAINEN, M., TUKIAINEN, E., ELOMAA, I. and KNUUTILA, S., Chromosome band 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer, 23, 183-186 (1998).
21. LONARDO, F., UEDA, T., HUVOS, A., HEALEY, J. and LADANYI, M., p53 and MDM2 alterations in osteosarcoma: correlation with clinicopathologic features and proliferative rate. Cancer, 79, 1541-1547 (1997).
22. MASUDA, H., MILLER, C., KOEFFLER, H.P., BATTIFORA, H. and CLINE, M.J., Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. nat. Acad. Sci. (Wash.), 84, 7716-7719 (1987).
23. MEYERS, P.A., HELLER, G., HEALEY, J.H., HUVOS, A., APPLEWHITE, A., SUN, M. and LAQUAGLIA, M., Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J. clin. Oncol., 11, 449-453 (1993).
24. MEYERS, P.A., HELLER, G., HEALEY, J., HUVOS, A., LANE, J., MARCOVE, R., APPLEWHITE, A., VLAMIS, V. and ROSEN, G., Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J. clin. Oncol., 10, 5-15 (1992).
25. MOCH, H., PRESTI, J.C., SAUTER, G., BUCHHOLZ, N., JORDAN, P., MIHATSCH, M.J. and WALDMAN, F.M., Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res., 56, 27-30 (1996).
26. NAKAYAMA, T., TOGUCHIDA, J., WADAYAMA, B., KANOE, H., KOTOURA, Y. and SASAKI, M.S., MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Int. J. Cancer, 64, 342-346 (1995).
27. NOBLE-TOPHAM, S.E., BURROW, S.R., EPPERT, K., KANDEL, R.A., MELTZER, P.S., BELL, R.S. and ANDRULIS, I.L.. SAS is amplified predominantly in surface osteosarcoma. J. orthop. Res., 14, 700-705 (1996).
28. OLINER, J.D., KINZLER, K.W., MELTZER, P.S., GEORGE, D.L. and VOGELSTEIN, B., Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358, 80-83 (1992).
29. ONDA, M., MATSUDA, S., HIGAKI, S., IIJIMA, T., FUKUSHIMA, J., YOKOKURA, A., KOJIMA, T., HORIUCHI, H., KUROKAWA, T. and YAMAMOTO, T., ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer, 77, 71-78 (1996).
30. PEDERSEN, B., MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases. Amer. J. Hematol., 56, 224-229 (1997).
31. POMPETTI, F., RIZZO, P., SIMON, R.M., FREIDLIN, B., MEW, D.J., PASS, H.I., PICCI, P., LEVINE, A.S. and CARBONE, M., Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J. cell. Biochem., 63, 37-50 (1996).
32. RICHTER, J., JIANG, F., GÖRÖG, J.-P., SARTORIUS, G., EGENTER, C., GASSER, T.C., MOCH, H., MIHATSCH, M.J. and SAUTER, G., Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57, 2860-2864 (1997).
33. ROSEN, G., MARCOVE, R.C., CAPARROS, B., NIRENBERG, A., KOSLOFF, C. and HUVOS, A.G., Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer, 43, 2163-2177 (1979).
34. SÆTER, G., ALVEGÅRD, T.A., ELOMAA, I., STENWIG, A.E., HOLMSTRÖM, T. and SOLHEIM, Ø.P., Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. J. clin. Oncol., 9, 1766-1775 (1991).
35. SÆTER, G., ALVEGÅRD, T.A., ELOMAA, I., WIEBE, T., BJÖRK, O., STRANDER, H. and SOLHEIM, Ø.P., Chemotherapy for osteosarcoma and Ewing's sarcoma. Acta orthop. Scand., 68, 120-125 (1997a).
36. SÆTER, G., ELOMAA, I., WAHLQVIST, Y., ALVEGÅRD, T.A., WIEBE, T., MONGE, O., FORRESTIER, E. and SOLHEIM, Ø.P., Prognostic factors in bone sarcomas. Acta orthop. Scand., 68, 156-160 (1997b).
37. SOUHAMI, R.L., CRAFT, A.W., VAN DER EIJKEN, J.W., NOOIJ, M., SPOONER, D., BRAMWELL, V.H.C., WIERZBICKI, R., MALCOLM, A.J., KIRKPATRICK, A., USCINSKA, B.M., VAN GLABBEKE, M. and MACHIN, D., Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet, 350, 911-917 (1997).
38. SZYMANSKA, J., TARKKANEN, M., WIKLUND, T., VIROLAINEN, M., BLOMQVIST, C., ASKO-SELJAVAARA, S., TUKIAINEN, E., ELOMAA, I. and KNUUTILA, S., Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer, 15, 89-94 (1996).
39. SZYMANSKA, J., VIROLAINEN, M., TARKKANEN, M., WIKLUND, T., ASKOSELJAVAARA, S., TUKIAINEN, E., ELOMAA, I., BLOMQVIST, C. and KNUUTILA, S., Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas. A comparative genomic hybridization study. Cancer Genet. Cytogenet., 99, 14-18 (1997).
40. TARKKANEN, M., KAIPAINEN, A., KARAHARJU, E., BÖHLING, T., SZYMANSKA, J., HELIÖ, H., KIVIOJA, A., ELOMAA, I. and KNUUTILA, S., Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet. Cytogenet., 68, 1-21 (1993).
41. TARKKANEN, M., KARHU, R., KALLIONIEMI, A., ELOMAA, I., KIVIOJA, A., NEVALAINEN, J., BÖHLING, T., KARAHARJU, E., HYYTINEN, E., KNUUTILA, S. and KALLIONIEMI, O.-P., Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res., 55, 1334-1338 (1995).
42. TOGUCHIDA, J., ISHIZAKI, K., SASAKI, M.S., IKENAGA, M., SUGIMOTO, M., KOTOURA, Y. and YAMAMURO, T., Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res., 48, 3939-3943 (1988).
43. WADAYAMA, B., TOGUCHIDA, J., SHIMIZU, T., ISHIZAKI, K., SASAKI, M.S., KOTOURA, Y. and YAMAMURO, T., Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res., 54, 3042-3048 (1994).
44. YAMAGUCHI, T., TOGUCHIDA, J., YAMAMURO, T., KOTOURA, Y., TAKADA, N., KAWAGUCHI, N., KANEKO, Y., NAKAMURA, Y., SASAKI, M.S. and ISHIZAKI, K., Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res., 52, 2419-2423 (1992).
45. ZHOU, D., BATTIFORA, H., YOKOTA, J., YAMAMOTO, T. and CLINE, M.J., Association of multiple copies of the c-erbS-2 oncogene with spread of breast cancer. Cancer Res., 47, 6123-6125 (1987).